Interestingly, when we divided HNSCCs according to the mutation status of p53, a curtail tumor suppressor gene that is extensively mutated in various human cancers, the PLAU was overexpressed in the p53 mutant group compared to the nonmutant group (Fig. 1e). This evidence concerns the gene TP53 and cancer.